The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

• DOI: 10.38045/ohrm.2020.1.02
• Publication Date: 2020-08-29T18:56:36Z
• Authors: Irina RUSU; ; Liliana HODOROGEA; ; Tiberiu HOLBAN
• Keywords: Antiviral Therapy; Hepatitis C; Viral Hepatitis

Introduction. Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV up to 80% patients, whom 10-20% can develop liver cirrhosis or hepatocellular carcinoma which lead death. Treatment with direct-acting antiviral agents (DAAs) contributes sustained virological response (SVR) in 97-99% cases.